Moebius syndrome is a rare neurological disorder characterized by facial paralysis and the inability to move the eyes laterally. Companies associated with Moebius syndrome may be involved in research, support services, or the development of treatments targeting the symptoms and challenges associated with the condition.
Latest Moebius Syndrome Companies Updates:
Telethon Foundation of Western Australia: Funded research led by the Telethon Kids Institute in July 2023, analyzing brain connectivity in individuals with Moebius Syndrome for a better understanding of the neurological mechanisms involved.
University of California, San Francisco: Researchers developed a gene therapy approach in mice in October 2023, showing potential for improving facial nerve development and restoring facial expressions in Moebius Syndrome models.
Symetrix Corporation: Received FDA approval for their Duoflex® Facial Pad System in December 2023, offering a non-surgical option for improving facial symmetry and smile function, potentially benefiting some Moebius Syndrome patients.
The Moebius Syndrome Foundation: Awarded research grants in January 2024 to two projects studying facial nerve development and gene therapy potential for Moebius Syndrome, emphasizing their commitment to supporting research advancements.
List of Moebius Syndrome Key companies in the market:
Moebius Syndrome Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)